Docmode Health Technologies

Consumer Services

DHTL NSE

NSE: DHTL E-Learning

₹21.20 −0.85 (−3.85%)

View as Markdown

MCP

Close 4 Nov 2026 ₹21.20 −97.80 −82.2% 1Y

Start ₹119.00

Key Fundamentals

SMEOther Consumer ServicesConsumer Services

Price-based figures as of 04 Nov 2026, 15:31 IST · TTM

ROCE: 6.12%
Debt to Equity: 0.45
EPS (TTM): —
Book Value: ₹26.14

Market Cap: —
P/E (TTM): —
P/B: 0.81
ROE: −1.57%
Dividend Yield: 0.00%
EBITDA: ₹1.10 Cr
52W High: ₹120.75
52W Low: ₹20.95
Day Range: ₹20.95 – ₹22.35
Volume: 5,600

Peer Comparison

Consumer Discretionary › Consumer Services › E-Learning

Docmode Health Technologies peer comparison

Physicswallah	₹127.41	849.40	₹37,257 Cr	10.01	0.00%	−0.63%	3.99%	₹4,106 Cr	₹15 Cr
Jaro Inst of Tech Mgmt & Research	₹334.45	13.12	₹733 Cr	2.06	1.52%	16.50%	22.10%	₹284 Cr	₹56 Cr
Veranda Learning Solutions	₹33.31	—	₹322 Cr	0.34	0.00%	3.84%	12.80%	₹525 Cr	₹159 Cr
Robokidz Eduventures	₹146.45	—	₹155 Cr	2.51	0.00%	40.20%	—	—	—
Fusion Klassroom Edutech	₹166.00	—	₹150 Cr	3.09	0.00%	53.40%	60.60%	—	—
Sodhani Academy of Fintech Enablers	₹168.00	—	₹97 Cr	5.59	0.44%	6.19%	12.80%	—	—
Jetking Infotrain	₹108.00	—	₹66 Cr	1.54	0.00%	−4.63%	−3.73%	₹21 Cr	−₹3 Cr
Docmode Health Technologies (this company)	₹21.20	—	₹7 Cr	0.81	0.00%	−1.57%	6.12%	—	—
Median 8 companies	₹136.93	431.26	₹153 Cr	2.29	0.00%	5.02%	12.80%	₹405 Cr	₹36 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of 25 Aug 2026. How it works →

Overall score

47 Average

Data confidence 84/100

Category scores

Quality: 65; Good; Returns, margins, earnings quality 22% weight
Valuation: 65; Good; Cheap vs sector & own history 24% weight
Growth: 51; Average; Sales & profit trajectory 9% weight
Financial Health: 13; Poor; Solvency, leverage, coverage 9% weight
Momentum: 10; Poor; Trend strength, vol-adjusted 12% weight
Ownership: 43; Weak; FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

Company has reduced debt.
Stock is trading at 0.90 times its book value

Weaknesses

Company has low interest coverage ratio.
Promoter holding has decreased over last quarter: -1.36%
Promoter holding is low: 29.5%
Company has a low return on equity of -8.02% over last 3 years.
Promoters have pledged 37.4% of their holding.
Earnings include an other income of Rs.1.40 Cr.
Company's cost of borrowing seems high

Technical Indicators

Technical signals: verdict and indicator counts
Group	Signal	Bearish	Neutral	Bullish
Overall	Strong Bearish	12	1	6
Oscillators	Strong Bullish	2	1	6
Moving Averages	Strong Bearish	10	0	0

Oscillators

Strong Bullish

Bearish

Neutral

Bullish

Overall

Strong Bearish

Bearish

Neutral

Bullish

Moving Averages

Strong Bearish

Bearish

Neutral

Bullish

Key readings

RSI (14): 25.71; Bullish
MACD (12,26,9): −3.03; Bearish
SMA (50): 31.35; Bearish
SMA (200): 58.71; Bearish

As of 4 Nov 2026

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y	+29.04%
3Y	−8.24%
1Y	−39.10%

Net profit

Net profit growth by window
5Y	Turned to loss
3Y	Turned to loss
1Y	Loss narrowed by ₹1.90 Cr

Operating cash flow

Operating cash flow growth by window
5Y	Turned positive
3Y	Turned positive
1Y	−35.63%

Operating margin· change in pp

Operating margin growth by window
5Y	−13.59 pp
3Y	−12.71 pp
1Y	+0.29 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2020	₹6.94 Cr
Mar 2021	₹7.10 Cr
Mar 2022	₹12.42 Cr
Mar 2023	₹32.88 Cr
Mar 2024	₹39.93 Cr
Mar 2025	₹41.71 Cr
Mar 2026	₹25.40 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020	₹0.34 Cr
Mar 2021	₹0.55 Cr
Mar 2022	₹0.92 Cr
Mar 2023	₹1.95 Cr
Mar 2024	₹0.19 Cr
Mar 2025	−₹2.03 Cr
Mar 2026	−₹0.13 Cr

Half-yearly Results

₹ Cr

DHTL half-yearly results, ₹ crore
Particulars	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	20.02	23.6	16.4	20.42	21.35	17.85	7.67
Expenses	18.58	20.88	17.23	20.54	21.97	17.05	8.83
Operating Profit	1.44	2.72	−0.83	−0.12	−0.62	0.8	−1.16
OPM %	7.19%	11.53%	−5.06%	−0.59%	−2.9%	4.48%	−15.12%
Other Income	0.05	0.06	0.07	0.84	0.09	0.07	1.32
Interest	0.72	0.84	0.82	1.09	0.83	0.85	0.11
Depreciation	0.01	0.02	0.01	0.14	0.16	0.11	0.12
PBT	0.76	1.92	−1.59	−0.51	−1.52	−0.09	−0.07
Tax %	18.42%	29.17%	−25.79%	1.96%	3.95%	0%	0%
Net Profit	0.61	1.36	−1.17	−0.52	−1.58	−0.09	−0.07
EPS (₹)	2.66	5.93	−3.72	−1.65	−5.03	−0.29	−0.22

Profit & Loss

₹ Cr

DHTL profit and loss, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	6.94	7.1	12.42	32.88	39.93	41.71	25.4
Expenses	6.55	6.23	10.53	29.14	38.05	42.39	25.74
Operating Profit	0.39	0.87	1.89	3.74	1.88	−0.68	−0.34
OPM %	5.62%	12.25%	15.22%	11.37%	4.71%	−1.63%	−1.34%
Other Income	0	0	0.01	0.1	0.14	0.93	1.4
Interest	0.01	0.19	0.38	1.13	1.66	1.92	0.97
Depreciation	0.05	0.04	0.02	0.02	0.02	0.3	0.23
PBT	0.33	0.64	1.5	2.69	0.34	−1.97	−0.14
Tax %	−6.06%	14.06%	38.67%	27.51%	44.12%	3.05%	−7.14%
Net Profit	0.34	0.55	0.92	1.95	0.19	−2.03	−0.13
EPS (₹)	—	—	—	8.5	0.6	−6.46	−0.41
Div. Payout %	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

₹ Cr

DHTL balance sheet, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.01	0.01	0.01	2.29	3.14	3.14	3.14
Reserves	−0.1	0.46	1.38	1.18	7.23	5.21	5.07
Borrowings	0.02	1.06	4.84	8.48	9.18	6.82	3.73
Other Liabilities	1.96	4.14	3.85	5.06	10.6	24.14	21.56
Total Liabilities	1.89	5.67	10.08	17.01	30.15	39.31	33.5
Fixed Assets	0.15	0.16	0.5	2.07	0.97	1.22	0.98
CWIP	0	0	0	0	8.5	11.6	13.48
Investments	0	0.1	1.25	1.2	1.26	1.29	1.3
Other Assets	1.74	5.41	8.33	13.74	19.42	25.2	17.74
Total Assets	1.89	5.67	10.08	17.01	30.15	39.31	33.5

Cash Flow

₹ Cr

DHTL cash flow, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating	0.17	−0.5	−2.05	−0.83	4.51	6.68	4.3
Investing	−0.2	−0.13	−1.52	−1.57	−7.55	−3.67	−1.89
Financing	0.01	0.84	3.41	2.65	5.76	−4.28	−4.06
Net Cash Flow	−0.03	0.21	−0.17	0.25	2.72	−1.27	−1.66
Free Cash Flow	−0.03	−0.54	−2.42	−2.43	−2.91	3.03	2.42
CFO/OP	46	−57	−103	−22	239	−1,001	−1,265

Ratios

DHTL financial ratios, annual
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0.53	69.92	112	92.03	105	80.86	107
Inventory Days	121	669	501	—	—	—	634
Days Payable	60.38	512	323	—	—	—	288
Cash Conversion Cycle	60.91	227	291	92.03	105	80.86	453
Working Capital Days	−22.62	30.33	92.28	50.07	11.61	−54.17	−95.85
ROCE %	—	113.7%	48.45%	42.02%	12.7%	−0.29%	6.12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

51 extracted metrics across FY20–FY26.

Shareholding Pattern

As of Sep 2026

Public 68.01%
Promoters 29.50%
Others 2.49%

37.37% of promoter holding pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Docmode Health Technologies

What does Docmode Health Technologies Ltd do?

Incorporated in 2017, Doctrack Solutions Ltd is engaged in the business of offering integrated learning solutions through online and offline learning models to healthcare professionals and learners.

Where is Docmode Health Technologies Ltd (DHTL) listed?

Docmode Health Technologies Ltd trades as DHTL on the NSE.

Which sector does Docmode Health Technologies Ltd belong to?

Docmode Health Technologies Ltd is classified under the Consumer Services sector, in the E-Learning industry.

What is the 52-week high and low of Docmode Health Technologies Ltd?

Over the last 52 weeks Docmode Health Technologies Ltd has traded between ₹20.95 and ₹120.75 as of 4 Nov 2026.

What is the Return on Equity (ROE) of Docmode Health Technologies Ltd?

Docmode Health Technologies Ltd reported a return on equity of -1.57%. Its debt-to-equity ratio is 0.45.

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DHTL.md for Docmode Health Technologies Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List FII and DII flows, month by month How Tapetide Scores changed, month by month Stocks mutual funds are buying, month by month

Docmode Health Technologies

Key Fundamentals

Peer Comparison

Overall score

Category scores

Key Insights

Strengths

Weaknesses

Technical Indicators

Oscillators

Overall

Moving Averages

Key readings

Growth Rate

Revenue

Net profit

Operating cash flow

Operating margin· change in pp

Revenue by year

Net profit by year

Half-yearly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Insights

Shareholding Pattern

Documents

Frequently Asked Questions about Docmode Health Technologies

Company Information

For AI agents and developers

Explore More